Mode
Text Size
Log in / Sign up

Drug-induced liver injury

Subtypes of Drug-induced liver injury

Hepatic adverse events 1

7 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for drug-induced liver injury

4 trials tracked for drug-induced liver injury: 2 in phase 3 or 4 and 1 with published results. The most-cited published study has 69 citations.

4Trials tracked
2Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 2 Phase 1 1 Other / NA 1
  1. Phase 4 Effect of Race/Ethnicity and Genes on Acetaminophen Pharmacokinetics Completed · 69 cited
  2. Phase 4 Acetaminophen Adduct Formation in Non-Drinkers Taking Therapeutic Doses of Acetaminophen for Ten Consecutive Days Completed
  3. Phase 1 Clinical Study to Evaluate Cannabidiol Liver Enzyme Elevations and Drug Interactions Completed
  4. N/A Sonoelastography: Ultrasound Method to Measure Liver Fibrosis Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about drug-induced liver injury

How is AI used to predict drug-induced liver injury in toxicogenomics?

AI and machine learning use toxicogenomic data, such as gene expression profiles and protein interaction networks, to predict which drugs may cause liver injury, with models reaching about 79% accuracy in one 2025 study [8].

Full answer →